Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia: results from the 24-month follow-up of the BELA trial - Brümmendorf, T H; Cortes, J E; de Souza, C A (Br J Haematol, 2015)
, et al.